Cel-Sci
CVM
#9766
Rank
NZ$89.51 M
Marketcap
NZ$11.20
Share price
2.54%
Change (1 day)
-60.79%
Change (1 year)

Cel-Sci (CVM) - Net assets

Net assets on the balance sheet as of June 2025 : NZ$12.19 Million

According to Cel-Sci 's latest financial reports the company has NZ$12.19 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Cel-Sci - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-09-30$NZ$20.27 M-8.01%
2023-09-30$NZ$22.04 M-61.37%
2022-09-30$NZ$57.05 M-30.39%
2021-09-30$NZ$81.97 M175.2%
2020-09-30$NZ$29.78 M263.34%
2019-09-30$NZ$8.19 M592668.88%
2018-09-30$NZ$0 M-100.03%
2017-09-30$-NZ$4.65 Million395.97%
2016-09-30$-NZ$0.94 Million-87.45%
2015-09-30$-NZ$7.46 Million-155.74%
2014-09-30$NZ$13.37 M65.58%
2013-09-30$NZ$8.07 M-4.86%
2012-09-30$NZ$8.48 M-28.24%
2011-09-30$NZ$11.82 M-68.84%
2010-09-30$NZ$37.96 M206.44%
2009-09-30$NZ$12.38 M-23.01%
2008-09-30$NZ$16.09 M-15.93%
2007-09-30$NZ$19.14 M-1442.54%
2006-09-30$-NZ$1.43 Million-146.79%
2005-09-30$NZ$3.04 M-50.34%
2004-09-30$NZ$6.13 M196.21%
2003-09-30$NZ$2.07 M-8.17%
2002-09-30$NZ$2.25 M-77.06%
2001-09-30$NZ$9.83 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Curis
CRIS
-NZ$25.51 Million-309.13%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-NZ$0.68 Billion-5,621.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$16.70 B 136,826.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$1.08 B 8,801.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$12.59 B 103,160.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
NZ$137.63 B 1,128,407.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$1.01 B 8,191.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ$6.19 M-49.18%๐Ÿ‡บ๐Ÿ‡ธ USA